Dawei Ding

1.4k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Dawei Ding is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Dawei Ding has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 7 papers in Molecular Biology and 7 papers in Biomaterials. Recurrent topics in Dawei Ding's work include Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Dawei Ding is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Dawei Ding collaborates with scholars based in China, Ireland and Singapore. Dawei Ding's co-authors include Mengying He, Ali Miserez, Huabing Chen, Tao Xu, Shahrouz Amini, Paul A. Guerette, Shawn Hoon, Tao Yang, Admir Mašić and Zhiyuan Zhong and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Dawei Ding

29 papers receiving 1.1k citations

Hit Papers

Reactive oxygen species-powered cancer immunotherapy: Cur... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawei Ding China 17 444 387 370 207 138 29 1.1k
Qilin Li China 23 436 1.0× 360 0.9× 478 1.3× 254 1.2× 114 0.8× 59 1.4k
Sunny Kumar India 12 383 0.9× 478 1.2× 492 1.3× 159 0.8× 135 1.0× 36 1.2k
Nathan D. Donahue United States 12 475 1.1× 407 1.1× 496 1.3× 307 1.5× 242 1.8× 16 1.3k
Marc P. Kai United States 10 387 0.9× 519 1.3× 380 1.0× 246 1.2× 170 1.2× 10 1.1k
Huapan Fang China 19 498 1.1× 266 0.7× 448 1.2× 255 1.2× 127 0.9× 43 1.1k
Daniel C. Pan United States 20 664 1.5× 484 1.3× 625 1.7× 369 1.8× 165 1.2× 29 1.7k
Randall Toy United States 16 779 1.8× 757 2.0× 429 1.2× 216 1.0× 310 2.2× 22 1.6k
Xiaoxiao Shi China 27 832 1.9× 683 1.8× 660 1.8× 167 0.8× 261 1.9× 76 1.9k
Jayanta Bhattacharyya India 18 338 0.8× 539 1.4× 513 1.4× 84 0.4× 90 0.7× 60 1.3k

Countries citing papers authored by Dawei Ding

Since Specialization
Citations

This map shows the geographic impact of Dawei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Ding more than expected).

Fields of papers citing papers by Dawei Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Ding. The network helps show where Dawei Ding may publish in the future.

Co-authorship network of co-authors of Dawei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Ding. A scholar is included among the top collaborators of Dawei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Ding. Dawei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Tianyi, Dazhao Li, Yi Han, et al.. (2025). Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells. Journal of Controlled Release. 378. 1080–1091. 3 indexed citations
3.
He, Mengying, Tao Xu, Dazhao Li, et al.. (2024). Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief. Journal of Controlled Release. 368. 233–250. 37 indexed citations
4.
He, Mengying, Yuhan Wang, Dazhao Li, et al.. (2023). Recent applications of phase-change materials in tumor therapy and theranostics. Biomaterials Advances. 147. 213309–213309. 19 indexed citations
5.
Li, Dazhao, et al.. (2023). Recent Advances of Tumor Microenvironment-Responsive Nanomedicines-Energized Combined Phototherapy of Cancers. Pharmaceutics. 15(10). 2480–2480. 10 indexed citations
6.
Ding, Dawei, Xue Jiao, Yufei Huang, et al.. (2023). Iron deposition in ovarian endometriosis evaluated by magnetic resonance imaging R2* correlates with ovarian function. Reproductive BioMedicine Online. 47(3). 103231–103231. 7 indexed citations
7.
He, Mengying, Tao Xu, Mengyao Zhang, et al.. (2023). Reactive oxygen species-powered cancer immunotherapy: Current status and challenges. Journal of Controlled Release. 356. 623–648. 105 indexed citations breakdown →
8.
He, Mengying, et al.. (2023). Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy. Biomaterials. 301. 122257–122257. 42 indexed citations
9.
Xu, Tao, et al.. (2022). Exploring the potential of polypeptide–polypeptoide hybrid nanogels for mucosal delivery. Polymer Chemistry. 13(42). 6054–6060. 6 indexed citations
10.
Chen, Xingye, Shan An, Lei Zhao, et al.. (2022). Enhancing adoptive T cell therapy for solid tumor with cell-surface anchored immune checkpoint inhibitor nanogels. Nanomedicine Nanotechnology Biology and Medicine. 45. 102591–102591. 10 indexed citations
11.
Wang, Yuhan, Chunyan Yue, Dazhao Li, et al.. (2022). Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment. Chemical Engineering Journal. 452. 139108–139108. 30 indexed citations
12.
He, Mengying, Tao Yang, Yuhan Wang, et al.. (2021). Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy. Advanced Healthcare Materials. 10(9). e2002104–e2002104. 65 indexed citations
13.
Luo, Lanxin, Xiudong Guan, Gulnaz Begum, et al.. (2020). Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis. Molecular Cancer Therapeutics. 19(7). 1550–1561. 19 indexed citations
14.
Iqbal, Haroon, Tao Yang, Ting Li, et al.. (2020). Serum protein-based nanoparticles for cancer diagnosis and treatment. Journal of Controlled Release. 329. 997–1022. 127 indexed citations
16.
Ding, Dawei, Jing Pan, Seng Han Lim, et al.. (2019). A miniaturized device for biomembrane permeation analysis. Materials Science and Engineering C. 103. 109772–109772. 6 indexed citations
17.
Ding, Dawei, Bingjun Sun, Qin Chen, et al.. (2018). Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel. Asian Journal of Pharmaceutical Sciences. 14(5). 552–558. 21 indexed citations
18.
Ma, Jingjing, Ying Gao, Yinghua Sun, et al.. (2017). Tissue distribution and dermal drug determination of indomethacin transdermal-absorption patches. Drug Delivery and Translational Research. 7(5). 617–624. 7 indexed citations
19.
Ding, Dawei, Xiaolei Tang, Jinhui Wu, et al.. (2013). Novel Self-assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy. AAPS PharmSciTech. 15(1). 213–222. 59 indexed citations
20.
Guerette, Paul A., Shawn Hoon, Yiqi Seow, et al.. (2013). Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science. Nature Biotechnology. 31(10). 908–915. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026